Clinical Journal of the American Society of Nephrology

Article	Citations
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis	253
Kidney Disease, Race, and GFR Estimation	162
Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19	150
Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China	130
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN)	119
APOL1 Nephropathy: From Genetics to Clinical Applications	115
Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications	102
Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients	95
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2	88
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2	87
Social Determinants of Health and Race Disparities in Kidney Transplant	84
Drug-Induced Acute Kidney Injury	80
The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019	78
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia	77
Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019	75
Klotho in Clinical Nephrology	74
Classification of Uremic Toxins and Their Role in Kidney Failure	74
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies	71
COVID-19 and the Inpatient Dialysis Unit	68
Skeletal Muscle Mitochondrial Dysfunction Is Present in Patients with CKD before Initiation of Maintenance Hemodialysis	67
Precision in GFR Reporting	65
Clinical Implications of an Acute Dip in eGFR after SGLT2 Inhibitor Initiation	64
Risk Factors for CKD Progression	63
Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation	63
Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers	63

Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis	62
Pathophysiology and Treatment of Enteric Hyperoxaluria	61
AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI	59
Utilization of Deep Learning for Subphenotype Identification in Sepsis-Associated Acute Kidney Injury	58
Fatigue in CKD	54
Long-Term Outcomes in IgA Nephropathy	53
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury	53
Cuffless Blood Pressure Monitoring	53
Clinical Genetic Screening in Adult Patients with Kidney Disease	52
Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19	52
Long-Term Immunosuppression Management	51
Guidelines for Genetic Testing and Management of Alport Syndrome	49
Adverse Drug Reactions in Patients with CKD	48
Inherited Tubulopathies of the Kidney	47
Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis	47
Major Bleeding and Risk of Death after Percutaneous Native Kidney Biopsies	47
COVID-19–Associated Mortality among Kidney Transplant Recipients and Candidates in the United States	47
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1	46
Deep Learning Model for Real-Time Prediction of Intradialytic Hypotension	45
Outcomes of COVID-19 in CKD Patients	45
Long-Term Infectious Complications of Kidney Transplantation	45
Nephrologist Follow-Up versus Usual Care after an Acute Kidney Injury Hospitalization (FUSION): A Randomized Controlled Trial	44
Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer	44
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD	43
Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy	42
Effect of Aerobic Exercise on Dialysis-Related Symptoms in Individuals Undergoing Maintenance Hemodialysis	42
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health	41
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months	41
COVID-19 in Peritoneal Dialysis Patients	41
Dietary Potassium Intake and All-Cause Mortality in Adults Treated with Hemodialysis	39
COVID-19 in Patients with Kidney Disease	38
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories	38
Intrauterine Growth Restriction and Risk of Diverse Forms of Kidney Disease during the First 50 Years of Life	37
Therapeutic Plasma Exchange Using Membrane Plasma Separation	37
Mortality and Recovery Associated with Kidney Failure due to Acute Kidney Injury	36
Validation of a Core Patient-Reported Outcome Measure for Fatigue in Patients Receiving Hemodialysis	36
Dialysis Regret	36
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria	36
The Pathophysiology of Sepsis-Associated AKI	36
Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients	36
Management of Heart Failure Patient with CKD	35
Severity of COVID-19 after Vaccination among Hemodialysis Patients	35
Recurrence of IgA Nephropathy after Kidney Transplantation in Adults	35
Clinical Integration of Genome Diagnostics for Congenital Anomalies of the Kidney and Urinary Tract	35
Environment-Wide Association Study of CKD	35
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease	35
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD	34
A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility	34
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome	34
Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19	34

Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes	33
Defining Early Recovery of Acute Kidney Injury	33
Vaccination and COVID-19 Dynamics in Dialysis Patients	33
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks	33
Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease	33
Prevalence of Kidney Injury and Associations with Critical Illness and Death in Patients with COVID-19	33
Impact of COVID-19 Pandemic in Children with CKD or Immunosuppression	32
Inherited Kidney Complement Diseases	32
Donor Age, Cold Ischemia Time, and Delayed Graft Function	31
De Novo Malignancies after Kidney Transplantation	31
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy	31
Updates in Diagnosis and Management of Preeclampsia in Women with CKD	31
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function	31
Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients	31
Genetic Basis of Type IV Collagen Disorders of the Kidney	30
Overweight and Obesity and Progression of ADPKD	30
Recurrent Glomerular Disease after Kidney Transplantation	29
Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients	29
Response to First Course of Intensified Immunosuppression in Genetically Stratified Steroid Resistant Nephrotic Syndrome	29
Low Serum Bicarbonate and CKD Progression in Children	29
Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care	29
Preimplantation Genetic Testing for Monogenic Kidney Disease	28
Association of Socioeconomic Status and Comorbidities with Racial Disparities during Kidney Transplant Evaluation	28
Metabolic Alkalosis	28
The Continuum of Acid Stress	28
Recovery after Critical Illness and Acute Kidney Injury	28
Association of Polypharmacy with Kidney Disease Progression in Adults with CKD	28
GWAS-Based Discoveries in IgA Nephropathy, Membranous Nephropathy, and Steroid-Sensitive Nephrotic Syndrome	28
Genome-Wide Association Studies of CKD and Related Traits	28
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy	28
Acute Kidney Injury and Risk of CKD and Hypertension after Pediatric Cardiac Surgery	27
Inequity in Access to Transplantation in the United Kingdom	27
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD	27
The Mobile Health Readiness of People Receiving In-Center Hemodialysis and Home Dialysis	27
Ambulatory Treatments for RAAS Inhibitor–Related Hyperkalemia and the 1-Year Risk of Recurrence	27
Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection	27
Identification of Patients with CKD in Medical Databases	27
COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression	27
Bioimpedance Guided Fluid Management in Peritoneal Dialysis	27
Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19)	26
Ertugliflozin and Slope of Chronic eGFR	26
JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy	26
Pilot Study of Return of Genetic Results to Patients in Adult Nephrology	26
Neural Epidermal Growth Factor–Like 1 Protein–Positive Membranous Nephropathy in Chinese Patients	26
Managing Patients with Failing Kidney Allograft	25
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum	25
Association of Depressive Symptoms with Rapid Kidney Function Decline in Adults with Normal Kidney Function	25
Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD	25
Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy	24
Long-Term Care of the Pediatric Kidney Transplant Recipient	24
Intradialytic Hypotension and Cardiac Arrhythmias in Patients Undergoing Maintenance Hemodialysis	24
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease	24
Preliminary Assessment of Acute Kidney Injury in Critically Ill Children Associated with SARS-CoV-2 Infection	24
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement	24
Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis	23
Video-Based Telemedicine for Kidney Disease Care	23
Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline	23
Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD	23
Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety	23
Characteristics of Acute Kidney Injury in Hospitalized COVID-19 Patients in an Urban Academic Medical Center	23
Kidney-Protective Effects of SGLT2 Inhibitors	23
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease	22
Assessing Global Kidney Nutrition Care	22
Reliability and Validity of the Patient Activation Measure in Kidney Disease: Results of Rasch Analysis	22
Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort	22
Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation	22
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination	22
SGLT2 Inhibitors in Diabetic Kidney Disease	22
Chronic Allograft Injury	21
Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis	21
Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis	21
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease	21
Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic	21
Depression Screening Tools for Patients with Kidney Failure	21
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease	21
Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism	20
Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project	20
Bone and Mineral Disease in Kidney Transplant Recipients	20
Acute Kidney Injury in Patients with Liver Disease	20
Expression of CD147 and Cyclophilin A in Kidneys of Patients with COVID-19	20

Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States	20
Provider Perception of Frailty Is Associated with Dialysis Decision Making in Patients with Advanced CKD	20
Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19	20
How COVID-19 Has Changed the Management of Glomerular Diseases	20
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis	20
Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice	19
Metabolic Acidosis and CKD Progression	19
Discontinuation of RAAS Inhibition in Children with Advanced CKD	19
Postoperative Acute Kidney Injury	19
The Pathogenesis of Race and Ethnic Disparities	19
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis	19
Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis	19
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes	19
External Validation of the International IgA Nephropathy Prediction Tool	19
Sex Disparity in Deceased-Donor Kidney Transplant Access by Cause of Kidney Disease	19
Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis	19
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood	19
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy	19
Evaluation of PROMIS Preference Scoring System (PROPr) in Patients Undergoing Hemodialysis or Kidney Transplant	19
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor–Associated Adverse Events	18
Metabolite Biomarkers of CKD Progression in Children	18
Mass Disasters and Burnout in Nephrology Personnel	18
Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients	18
Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide	18
Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD	18
What Does Uromodulin Do?	18
Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient	18
Prevalence and Risk Factors for Kidney Disease and Elevated BP in 2-Year-Old Children Born Extremely Premature	17
Soluble Klotho and Incident Hypertension	17
Associations between Deprivation, Geographic Location, and Access to Pediatric Kidney Care in the United Kingdom	17
The Seen and the Unseen: Race and Social Inequities Affecting Kidney Care	17
Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD	17
Digenic Alport Syndrome	17
Social Determinants of Kidney Health	17
The Kidney in Normal Aging	17
Low-Flow Acute Kidney Injury	17
Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD	17
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease	17
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan	17
NephroTalk Multimodal Conservative Care Curriculum for Nephrology Fellows	16
Addressing Polypharmacy in Outpatient Dialysis Units	16
Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis	16
Symptom Burden before and after Dialysis Initiation in Older Patients	16
Kidney Disease Symptoms before and after Kidney Transplantation	16
SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis	16
Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease	16
Waiting Time for Second Kidney Transplantation and Mortality	16
Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness	16
Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression	16
The Curious Story of Cerebral Salt Wasting	16
Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease	15
Effect of the Refitted Race-Free eGFR Formula on the CKD Prevalence and Mortality in the Danish Population	15
Post-Transplant Cardiovascular Disease	15
Uric Acid and CKD Progression Matures with Lessons for CKD Risk Factor Discovery	15
Transplant Clinician Opinions on Use of Race in the Estimation of Glomerular Filtration Rate	15
Digital Applications Targeting Medication Safety in Ambulatory High-Risk CKD Patients	15
Electrolyte and Acid-Base Disorders Associated with Cancer Immunotherapy	15
Use of Race in Kidney Research and Medicine	15
Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD	15
Intravenous Albumin for Mitigating Hypotension and Augmenting Ultrafiltration during Kidney Replacement Therapy	15
In-Hospital and 1-Year Mortality Trends in a National Cohort of US Veterans with Acute Kidney Injury	15
Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy	15
Metabolites Associated with Coffee Consumption and Incident Chronic Kidney Disease	14
Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse	14
Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese	14
Urinary Cell mRNA Profiles Predictive of Human Kidney Allograft Status	14
Challenges with Providing Hospice Care for Patients Undergoing Long-Term Dialysis	14
Variation in Peritoneal Dialysis Time on Therapy by Country	14
Severe Acute Kidney Injury and Mortality in Extremely Low Gestational Age Neonates	14
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury	14
Mortality and Access to Kidney Transplantation in Patients with Sickle Cell Disease–Associated Kidney Failure	14
Food Insecurity and Kidney Disease	14
Kidney Effects of Empagliflozin in People with Type 1 Diabetes	14
Predictive Approaches for Acute Dialysis Requirement and Death in COVID-19	14
The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function	14
Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients	14
Collectin11 and Complement Activation in IgA Nephropathy	14
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria	14
Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019	13
The Elusive Promise of Bioimpedance in Fluid Management of Patients Undergoing Dialysis	13
Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease	13
Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease	13
Plasma Endothelin-1 and Risk of Death and Hospitalization in Patients Undergoing Maintenance Hemodialysis	13
Racial Differences in Risk Factors for Kidney Stone Formation	13
NAT8 Variants, N-Acetylated Amino Acids, and Progression of CKD	13
Beyond the Biopsy: Monitoring Immune Status in Kidney Recipients	13
Long-Term Effect of Physical Exercise on the Risk for Hospitalization and Death in Dialysis Patients	13
Donor Age, Donor-Recipient Size Mismatch, and Kidney Graft Survival	13
Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019	13
Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis	13
Infection-Related Acute Care Events among Patients with Glomerular Disease	13
Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies	13
The Importance of Kidney Medullary Tissue for the Accurate Diagnosis of BK Virus Allograft Nephropathy	13
Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery	13
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance	13